Research Corporation for Science Advancement has an investment portfolio valued at over $194.65 million as of December 31, 2022, covering domestic and international equity, fixed income, hedge funds, private equity, real estate, cash and other alternatives. On December 31, 2021, private equity holdings were valued at $7.07 million, or 3.6% of the total portfolio, up from $4.87 million on December 30, 2021. The unfunded commitment in PE Funds on December 31, 2021 was valued at $27.875 million. The board of directors governs the foundation's investments, with Mr. Daniel Gasch as Chief Financial Officer & Vice President.
| Investor | Type | Based in | Focus | AUM | Contacts |
|---|---|---|---|---|---|
| Morgan Stanley Investment Management | Fund of Funds | New York | Debt & credit · Core · Co-investment | $1.6T | 1 |
| Blackstone Group - Fund of Funds and Secondary | Fund of Funds | New York | Multifamily · Industrial · Core | $1.1T | 16 |
| New York Life Investment Management | Asset Manager | New York | Multifamily · Industrial · Co-investment | $740B | 5 |
| Brookfield Asset Management | Asset Manager | Toronto, Canada | Multifamily · Industrial · Opportunistic · Joint venture | $690B | 12 |
| KKR | Asset Manager | New York | Multifamily · Industrial · Core · Co-investment | $553B | 11 |
| Ares Management | Asset Manager | Los Angeles | Multifamily · Industrial · Core | $546B | 16 |
Filter the full list by property type, strategy, market and deal format.
